Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.100 |
None |
1.000 |
15 |
|
2011 |
2020 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
1.000 |
12 |
|
2005 |
2020 |
Clear Cell Sarcoma of Soft Tissue
|
disease |
Neoplasms
|
Neoplastic Process
|
51
|
2
|
0.090 |
None |
1.000 |
9 |
|
2002 |
2020 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.060 |
None |
1.000 |
6 |
|
2011 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.060 |
None |
1.000 |
6 |
|
2005 |
2019 |
Malignant neoplasm of kidney
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
664
|
22
|
0.060 |
None |
1.000 |
6 |
|
2011 |
2019 |
MiT family translocation renal cell carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
33
|
|
0.040 |
None |
1.000 |
4 |
|
2014 |
2019 |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
302
|
92
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2017 |
Addictive Behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
332
|
56
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2019 |
Perivascular Epithelioid Cell Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
31
|
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2018 |
Vitiligo
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
395
|
249
|
0.030 |
None |
1.000 |
3 |
|
2004 |
2017 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2017 |
Malignant neoplasm of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3806
|
615
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2020 |
Albinism, Oculocutaneous
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Skin and Connective Tissue Diseases
|
Congenital Abnormality
|
49
|
45
|
0.310 |
None |
1.000 |
2 |
|
1997 |
2017 |
Dystopia canthorum
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
3
|
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2007 |
Adult Soft Tissue Sarcoma
|
disease |
|
Neoplastic Process
|
162
|
3
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2020 |
Histiocytoma, Angiomatoid Fibrous
|
disease |
Neoplasms
|
Neoplastic Process
|
28
|
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2007 |
Childhood Soft Tissue Sarcoma
|
disease |
|
Neoplastic Process
|
166
|
3
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2020 |
WAARDENBURG SYNDROME, TYPE 4A
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases
|
Disease or Syndrome
|
12
|
11
|
0.310 |
None |
1.000 |
2 |
|
2019 |
2019 |
Pigmentation Disorders
|
group |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
16
|
|
0.310 |
None |
1.000 |
2 |
|
1997 |
2017 |
Anaplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
538
|
7
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2015 |
Non-Metastatic Childhood Soft Tissue Sarcoma
|
disease |
|
Neoplastic Process
|
160
|
3
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2020 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |
Chloasma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
25
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |
B-Cell Lymphomas
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1408
|
42
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2017 |